Why AstraZeneca’s CEO is accusing British tabloids of ‘fake news’

Off Biotech, biotechnology, drug development, FDA, finance, genetics, Health, health care, Human Health, Life Sciences, Medicine, Pharma, research, Science and Research, The Regulars

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, everyone. Damian here with news of a 2021-sized biotech round that has echoes of 2011, plus an ESMO recap and a curious stock move.

Read the rest…

Read Original Article: Why AstraZeneca’s CEO is accusing British tabloids of ‘fake news’ »

About The Author